Cargando…

Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray

A coronavirus antigen microarray (COVAM) was constructed containing 11 SARS-CoV-2, 5 SARS-1, 5 MERS, and 12 seasonal coronavirus recombinant proteins. The array is designed to measure immunoglobulin isotype and subtype levels in serum or plasma samples against each of the individual antigens printed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assis, Rafael, Jain, Aarti, Nakajima, Rie, Jasinskas, Algis, Khan, Saahir, Davies, Huw, Corash, Laurence, Dumont, Larry J., Kelly, Kathleen, Simmons, Graham, Stone, Mars, Di Germanio, Clara, Busch, Michael, Felgner, Philip L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024395/ https://www.ncbi.nlm.nih.gov/pubmed/33824382 http://dx.doi.org/10.1038/s41598-021-87137-7

Ejemplares similares

Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray
por: de Assis, Rafael R., et al.
Publicado: (2020)

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray
por: de Assis, Rafael R., et al.
Publicado: (2021)

Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray
por: Khan, Saahir, et al.
Publicado: (2020)

A Modular Microarray Imaging System for Highly Specific COVID-19 Antibody Testing
por: Hedde, Per Niklas, et al.
Publicado: (2020)

A modular microarray imaging system for highly specific COVID-19 antibody testing
por: Hedde, Per Niklas, et al.
Publicado: (2020)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray
por: Hosseinian, Sina, et al.
Publicado: (2022)

Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies
por: Nakajima, Rie, et al.
Publicado: (2018)

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study
por: Khanna, Nina, et al.
Publicado: (2020)

A Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance
por: Beck, Sungjun, et al.
Publicado: (2022)

Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population
por: Khan, Saahir, et al.
Publicado: (2022)

Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination
por: Assis, Rafael, et al.
Publicado: (2021)

Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients
por: Weisser, Maja, et al.
Publicado: (2022)

The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae
por: Ercoli, Giuseppe, et al.
Publicado: (2021)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children
por: Felgner, Jiin, et al.
Publicado: (2017)

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination
por: Goll, Johannes B., et al.
Publicado: (2022)

Multivalent vaccines demonstrate immunogenicity and protect against Coxiella burnetii aerosol challenge
por: Jan, Sharon, et al.
Publicado: (2023)

Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice
por: Dotsey, Emmanuel, et al.
Publicado: (2017)

Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population
por: Hosseinian, Sina, et al.
Publicado: (2023)

Linked Toll-Like Receptor Triagonists Stimulate Distinct, Combination-Dependent Innate Immune Responses
por: Albin, Tyler J., et al.
Publicado: (2019)

Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine
por: Ramirez, Aaron, et al.
Publicado: (2023)

Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses
por: Fratzke, Alycia P., et al.
Publicado: (2021)

Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019
por: Bainbridge, Emma D, et al.
Publicado: (2021)

Distinct antibody responses of patients with mild and severe leptospirosis determined by whole proteome microarray analysis
por: Lessa-Aquino, Carolina, et al.
Publicado: (2017)

Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2022)

Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid
por: Liang, Li, et al.
Publicado: (2013)

Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation
por: Van Rompay, Koen K.A., et al.
Publicado: (2021)

Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology
por: Carroll, Timothy D., et al.
Publicado: (2023)

Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation
por: Van Rompay, Koen K. A., et al.
Publicado: (2022)

Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020)

Identification of the Feline Humoral Immune Response to Bartonella henselae Infection by Protein Microarray
por: Vigil, Adam, et al.
Publicado: (2010)

Identification of Seroreactive Proteins of Leptospira interrogans Serovar Copenhageni Using a High-Density Protein Microarray Approach
por: Lessa-Aquino, Carolina, et al.
Publicado: (2013)

Protein Nanoparticle-Mediated Delivery of Recombinant Influenza Hemagglutinin Enhances Immunogenicity and Breadth of the Antibody Response
por: Badten, Alexander J., et al.
Publicado: (2023)

Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA
por: Corash, Laurence, et al.
Publicado: (2021)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines
por: Cardenas-Garcia, Stivalis, et al.
Publicado: (2021)

The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Shi, Ming, et al.
Publicado: (2021)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fndc2tjr0mmfjc89hf8v80t7b1